Global Influenza Virus Rapid Antigen Test Kit Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
The Influenza Virus Rapid Antigen Test Kit is a diagnostic tool designed for the rapid detection of influenza virus antigens in patient samples. Utilizing specific antibodies, this kit enables healthcare professionals to quickly screen for the presence of influenza virus, aiding in the timely diagnosis and management of influenza infections. This rapid antigen test kit provides a convenient and efficient method for frontline healthcare workers to identify influenza cases, facilitating prompt treatment and containment measures during flu outbreaks.
According to our (Global Info Research) latest study, the global Influenza Virus Rapid Antigen Test Kit market size was valued at US$ 218 million in 2023 and is forecast to a readjusted size of USD 294 million by 2030 with a CAGR of 4.2% during review period.
This report is a detailed and comprehensive analysis for global Influenza Virus Rapid Antigen Test Kit market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Influenza Virus Rapid Antigen Test Kit market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Influenza Virus Rapid Antigen Test Kit market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Influenza Virus Rapid Antigen Test Kit market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Influenza Virus Rapid Antigen Test Kit market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Influenza Virus Rapid Antigen Test Kit
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Influenza Virus Rapid Antigen Test Kit market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BD, Abbott, Quidel, Roche, Actim, Denka, Guangzhou Wondfo Biotech, Jiangsu Bioperfectus Technologies, Hangzhou Biotest Biotech, Wantai BioPharm, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Influenza Virus Rapid Antigen Test Kit market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Conventional RIDT
Digital RIDT
Market segment by Application
Hospital
POCT
Others
Major players covered
BD
Abbott
Quidel
Roche
Actim
Denka
Guangzhou Wondfo Biotech
Jiangsu Bioperfectus Technologies
Hangzhou Biotest Biotech
Wantai BioPharm
Daan Gene
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Influenza Virus Rapid Antigen Test Kit product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Influenza Virus Rapid Antigen Test Kit, with price, sales quantity, revenue, and global market share of Influenza Virus Rapid Antigen Test Kit from 2019 to 2024.
Chapter 3, the Influenza Virus Rapid Antigen Test Kit competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Influenza Virus Rapid Antigen Test Kit breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Influenza Virus Rapid Antigen Test Kit market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Influenza Virus Rapid Antigen Test Kit.
Chapter 14 and 15, to describe Influenza Virus Rapid Antigen Test Kit sales channel, distributors, customers, research findings and conclusion.